Overview

• Jamie Holson was diagnosed with stage four alveolar rhabdomyosarcoma in June 2023, a rare soft tissue cancer affecting about 31 people in England each year.
• Two courses of chemotherapy produced remissions in December 2023 and February 2025 but the disease relapsed in May 2024 and again in April 2025.
• After NHS treatment options were exhausted, the family launched a GoFundMe campaign in September 2024 and raised over £300,000 for specialized care abroad.
• Since June 2025 Jamie has been undergoing genomic profiling and personalized immunotherapy at a German clinic and is showing positive responses.
• Most of the initial funds have been spent and the Holsons need an additional £300,000 to cover bespoke vaccine doses (€5,000–€20,000 each) and nightly clinic fees (€1,300).